AAAAAA

   
Results: 1-25 | 26-33 |
Results: 26-33/33
AN APPROACH TO QUANTITATING NORMAL CFTR MESSENGER-RNA FOR GENOTYPE-PHENOTYPE STUDIES
Authors: ZHOU Z OLSEN JC SILVERMAN LM BOUCHER RC KNOWLES MR
Citation: Z. Zhou et al., AN APPROACH TO QUANTITATING NORMAL CFTR MESSENGER-RNA FOR GENOTYPE-PHENOTYPE STUDIES, American journal of human genetics, 57(4), 1995, pp. 1477-1477
GENE-THERAPY FOR CYSTIC-FIBROSIS USING E1-DELETED ADENOVIRUS - A PHASE-I TRIAL IN THE NASAL CAVITY - THE UNIVERSITY-OF-NORTH-CAROLINA AT CHAPEL-HILL
Authors: BOUCHER RC KNOWLES MR JOHNSON LG OLSEN JC PICKLES R WILSON JM ENGELHARDT J YANG YP GROSSMAN M
Citation: Rc. Boucher et al., GENE-THERAPY FOR CYSTIC-FIBROSIS USING E1-DELETED ADENOVIRUS - A PHASE-I TRIAL IN THE NASAL CAVITY - THE UNIVERSITY-OF-NORTH-CAROLINA AT CHAPEL-HILL, Human gene therapy, 5(5), 1994, pp. 615-639
A NOVEL MUTATION IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH PULMONARY-DISEASE BUT NORMAL SWEAT CHLORIDE CONCENTRATIONS
Authors: HIGHSMITH WE BURCH LH ZHOU ZQ OLSEN JC BOAT TE SPOCK A GORVOY JD QUITTELL L FRIEDMAN KJ SILVERMAN LM BOUCHER RC KNOWLES MR
Citation: We. Highsmith et al., A NOVEL MUTATION IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH PULMONARY-DISEASE BUT NORMAL SWEAT CHLORIDE CONCENTRATIONS, The New England journal of medicine, 331(15), 1994, pp. 974-980
CLONING AND EXPRESSION OF A HUMAN-P(2U) NUCLEOTIDE RECEPTOR, A TARGETFOR CYSTIC-FIBROSIS PHARMACOTHERAPY
Authors: PARR CE SULLIVAN DM PARADISO AM LAZAROWSKI ER BURCH LH OLSEN JC ERB L WEISMAN GA BOUCHER RC TURNER JT
Citation: Ce. Parr et al., CLONING AND EXPRESSION OF A HUMAN-P(2U) NUCLEOTIDE RECEPTOR, A TARGETFOR CYSTIC-FIBROSIS PHARMACOTHERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 91(8), 1994, pp. 3275-3279
CLONING AND EXPRESSION OF A HUMAN P-2U NUCLEOTIDE RECEPTOR, A TARGET FOR CYSTIC-FIBROSIS PHARMACOTHERAPY (VOL 91, PG 3275, 1994)
Authors: PARR CE SULLIVAN DM PARADISO AM LAZAROWSKI ER BURCH LH OLSEN JC ERB L WEISMAN GA BOUCHER RC TURNER JT
Citation: Ce. Parr et al., CLONING AND EXPRESSION OF A HUMAN P-2U NUCLEOTIDE RECEPTOR, A TARGET FOR CYSTIC-FIBROSIS PHARMACOTHERAPY (VOL 91, PG 3275, 1994), Proceedings of the National Academy of Sciences of the United Statesof America, 91(26), 1994, pp. 13067-13067
PYRIDINE-NUCLEOTIDE REDOX POTENTIAL MODULATES CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CL- CONDUCTANCE
Authors: STUTTS MJ GABRIEL SE PRICE EM SARKADI B OLSEN JC BOUCHER RC
Citation: Mj. Stutts et al., PYRIDINE-NUCLEOTIDE REDOX POTENTIAL MODULATES CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CL- CONDUCTANCE, The Journal of biological chemistry, 269(12), 1994, pp. 8667-8674
HIGH-EFFICIENCY GENE-TRANSFER TO PRIMARY MONKEY AIRWAY EPITHELIAL-CELLS WITH RETROVIRUS VECTORS USING THE GIBBON APE LEUKEMIA-VIRUS RECEPTOR
Authors: BAYLE JY JOHNSON LG STGEORGE JA BOUCHER RC OLSEN JC
Citation: Jy. Bayle et al., HIGH-EFFICIENCY GENE-TRANSFER TO PRIMARY MONKEY AIRWAY EPITHELIAL-CELLS WITH RETROVIRUS VECTORS USING THE GIBBON APE LEUKEMIA-VIRUS RECEPTOR, Human gene therapy, 4(2), 1993, pp. 161-170
FUNCTIONAL CONSEQUENCES OF HETEROLOGOUS EXPRESSION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IN FIBROBLASTS
Authors: STUTTS MJ GABRIEL SE OLSEN JC GATZY JT OCONNELL TL PRICE EM BOUCHER RC
Citation: Mj. Stutts et al., FUNCTIONAL CONSEQUENCES OF HETEROLOGOUS EXPRESSION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IN FIBROBLASTS, The Journal of biological chemistry, 268(27), 1993, pp. 20653-20658
Risultati: 1-25 | 26-33 |